Integrating Health Data-Driven Machine Learning Algorithms to Evaluate Risk Factors of Early Stage Hypertension at

Pen-Chih Liao1, Ming-Shu Chen2, Mao-Jhen Jhou3

  • 1Division of Cardiology, Cardiovascular Center, Far Eastern Memorial Hospital, New Taipei City 220, Taiwan.

Insights

High LDL cholesterol, not low HDL, is a key predictor of early hypertension in adults with dyslipidemia. This finding aids in early detection and prevention strategies for cardiovascular disease.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Data Science

Background:

  • Cardiovascular disease (CVD) poses a significant global health challenge.
  • Hypertension and hyperlipidemia are primary CVD risk factors.
  • Early hypertension in dyslipidemic populations is a critical public health concern.

Purpose of the Study:

  • To investigate the association between dyslipidemia and early-stage hypertension incidence.
  • To apply machine learning to analyze complex risk factor-outcome relationships.
  • To identify key risk factors for hypertension in individuals with normal baseline blood pressure.

Main Methods:

  • Analysis of health screening data from 71,108 individuals (2005-2017).
  • Utilized five machine learning methods: SGB, MARS, Lasso, Ridge, and CatBoost.
  • Evaluated risk factors, particularly LDL-C and HDL-C levels, for early hypertension prediction.

Main Results:

  • Age, BMI, waist circumference, waist-to-hip ratio, fasting plasma glucose, CRP, and hemoglobin were associated with hypertension.
  • Increased LDL-C levels showed a residual contribution to blood pressure elevation.
  • Hemoglobin was a top risk factor across all LDL-C/HDL-C groups.

Conclusions:

  • Increased LDL-C is a more critical indicator than decreased HDL-C for hypertension risk in sub-healthy adults.
  • Machine learning models identified key risk factors for early hypertension.
  • Findings support enhanced health awareness and follow-up research for hypertension prevention.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
26
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
45
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
47
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
32
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
949